These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 3168695

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Lack of dose-response with Pancrease MT for the treatment of exocrine pancreatic insufficiency in adults.
    Opekun AR, Sutton FM, Graham DY.
    Aliment Pharmacol Ther; 1997 Oct; 11(5):981-6. PubMed ID: 9354210
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Therapy of pancreatogenic steatorrhea. Comparison of 2 acid-protected enzyme preparations].
    Lankisch PG, Lembcke B, Kirchhoff S, Hilgers R, Creutzfeldt W.
    Dtsch Med Wochenschr; 1988 Jan 08; 113(1):15-7. PubMed ID: 3335192
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Comparative study of the effect of kreon and cotazyme forte in children with cystic fibrosis].
    Zsíros J, Sólyom E.
    Orv Hetil; 1988 May 08; 129(19):995-9. PubMed ID: 3290773
    [No Abstract] [Full Text] [Related]

  • 30. Properties of different pancreatin preparations used in pancreatic exocrine insufficiency.
    Löhr JM, Hummel FM, Pirilis KT, Steinkamp G, Körner A, Henniges F.
    Eur J Gastroenterol Hepatol; 2009 Sep 08; 21(9):1024-31. PubMed ID: 19352190
    [Abstract] [Full Text] [Related]

  • 31. Optimal size range for enteric-coated pancreatin preparations.
    Lederer PC.
    Pancreas; 2011 Mar 08; 40(2):310-1. PubMed ID: 21311309
    [No Abstract] [Full Text] [Related]

  • 32. Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) century.
    Trang T, Chan J, Graham DY.
    World J Gastroenterol; 2014 Sep 07; 20(33):11467-85. PubMed ID: 25206255
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Fate of pancreatic enzymes in the human intestinal lumen in health and pancreatic insufficiency.
    Layer P, Gröger G.
    Digestion; 1993 Sep 07; 54 Suppl 2():10-4. PubMed ID: 7693530
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Comparative trial of viokase, pancreatin and Pancrease pancrelipase (enteric coated beads) in the treatment of malabsorption in cystic fibrosis.
    Mitchell EA, Quested C, Marks RE, Pinnock RE, Elliott RB.
    Aust Paediatr J; 1982 Jun 07; 18(2):114-7. PubMed ID: 6923744
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The effect of enzyme substitution in patients with pancreatic insufficiency.
    Worning H.
    Scand J Gastroenterol; 1980 Jun 07; 15(5):529-33. PubMed ID: 6160608
    [Abstract] [Full Text] [Related]

  • 40. Solubility of oral pancreatic enzyme supplement capsules in biological fluids.
    Robb TS, Davidson GP, Cooper DM.
    Lancet; 1980 Sep 06; 2(8193):544. PubMed ID: 6105599
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.